The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation from Dr. Yair Lotan ...

Table 1. Metric comparison between robotic and laparoscopic donor nephrectomy approaches.

The immune checkpoint inhibitor combination regimen has become the initial standard of care for metastatic RCC, given its ...

In a real-world, multi-center cohort, patients receiving LHRH agonists as compared to LHRH antagonists were found to be at ...

WCET 2025: Suction Technology Utility in Mini-PCNL Study: Results of a Real World Multicenter Registry on Behalf of the Endourology Section of the European Association of Urology and the Suction Mini ...

Moderated by Dr. Thomas Chi (UAB), the panel featured Dr. Vernon Pais (Dartmouth), Dr. Karen Stern (Mayo Clinic Arizona), Dr.

Neoadjuvant systemic therapy was acceptable to 70% of patients, with 69% of those willing to undergo renal mass biopsy first. While 52% would consider neoadjuvant systemic therapy for ≥16 weeks and 56 ...

Detalimogene voraplasmid is a novel, investigational, non-integrating, non-viral genetic medicine-based immunotherapy carrying a plasmid that simultaneously expresses IL-12 and regulators of RIG-I.

In the past 20 years, minimally invasive surgery has become the standard, Dr. Zhang began. Robotics now propels us into a new age of development, with three-dimensional vision and complete freedom of ...

(UroToday.com) The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation from Dr. Janet Kukreja discussing a pilot study of a web-based urinary diversion ...

The baseline characteristics of the two cohorts are as follows: ...

The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a trials in progress presentation from Dr. Yair Lotan discussing a streamlined, patient-centric design of the ...